P. McEwan

First name
Last name
James, G., Kim, J., Mellström, C., Ford, K. L., Jenkins, N. C., Tsang, C., et al. (2022). Serum potassium variability as a predictor of clinical outcomes in patients with cardiorenal disease or diabetes: a retrospective UK database study. Clin Kidney J, 15, 758-770. http://doi.org/10.1093/ckj/sfab225
McEwan, P., Thorsted, L., Wolden, M., Jacobsen, J., & Evans, M. (2015). Healthcare resource implications of hypoglycemia-related hospital admissions and inpatient hypoglycemia: retrospective record-linked cohort studies in England. BMJ Open Diabetes Res Care. http://doi.org/10.1136/bmjdrc-2014-000057
Pockett, R. D., Watkins, J., McEwan, P., & Meier, G. (2015). Burden of Illness in UK Subjects with Reported Respiratory Infections Vaccinated or Unvaccinated against Influenza: A Retrospective Observational Study. PLoS One. http://doi.org/10.1371/journal.pone.0134928
Gordon, J., McEwan, P., Evans, M., Puelles, J., & Sinclair, A. (2017). Managing glycaemia in older people with type 2 diabetes: A retrospective, primary care-based cohort study, with economic assessment of patient outcomes. Diabetes Obes Metab. http://doi.org/10.1111/dom.12867
Furuland, H., McEwan, P., Evans, M., Linde, C., Ayoubkhani, D., Bakhai, A., et al. (2018). Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink. BMC Nephrol. http://doi.org/10.1186/s12882-018-1007-1
Gordon, J., McEwan, P., Idris, I., Evans, M., & Puelles, J. (2018). Treatment choice, medication adherence and glycemic efficacy in people with type 2 diabetes: a UK clinical practice database study. BMJ Open Diabetes Res Care. http://doi.org/10.1136/bmjdrc-2018-000512
Hill, N. R., Ayoubkhani, D., McEwan, P., Sugrue, D. M., Farooqui, U., Lister, S., et al. (2019). Predicting atrial fibrillation in primary care using machine learning. PLoS One. http://doi.org/10.1371/journal.pone.0224582
Linde, C., Bakhai, A., Furuland, H., Evans, M., McEwan, P., Ayoubkhani, D., & Qin, L. (2019). Real-World Associations of Renin-Angiotensin-Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New-Onset Chronic Kidney Disease or Heart Failure in the United Kingdom. J Am Heart Assoc. http://doi.org/10.1161/jaha.119.012655
Linde, C., Qin, L., Bakhai, A., Furuland, H., Evans, M., Ayoubkhani, D., et al. (2019). Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK. ESC Heart Fail. http://doi.org/10.1002/ehf2.12402
Strain, W. D., Tsang, C., Hurst, M., McEwan, P., Unadkat, M., Meadowcroft, S., et al. (2020). What Next After Metformin in Type 2 Diabetes? Selecting the Right Drug for the Right Patient. Diabetes Ther. http://doi.org/10.1007/s13300-020-00834-w